USE OF RAPAMYCIN COMBINED WITH PD-1 MONOCLONAL ANTIBODY IN PREPARATION OF DRUGS FOR TREATING COLORECTAL CANCER
AU2023463215A1 · Application publication visible
immortal.lifeExplore source-linked longevity patent families and topic connections associated with the applicant name GUANGZHOU PENGXING MEDICAL TECHNOLOGY CO LTD [CN].
This independent page groups EPO bibliographic records in which this name appears as an applicant or assignee. It is not a corporate profile, ownership opinion, portfolio valuation or ranking.
AU2023463215A1 · Application publication visible